mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.18 |
0.003 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |